首页> 美国卫生研究院文献>International Journal of Molecular Sciences >MicroRNAs in Acute ST Elevation Myocardial Infarction—A New Tool for Diagnosis and Prognosis: Therapeutic Implications
【2h】

MicroRNAs in Acute ST Elevation Myocardial Infarction—A New Tool for Diagnosis and Prognosis: Therapeutic Implications

机译:MicroRNAS在急性ST升高的心肌梗死 - 一种诊断和预后的新工具:治疗意义

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Despite diagnostic and therapeutic advances, coronary artery disease and especially its extreme manifestation, ST elevation myocardial infarction (STEMI), remain the leading causes of morbidity and mortality worldwide. Early and prompt diagnosis is of great importance regarding the prognosis of STEMI patients. In recent years, microRNAs (miRNAs) have emerged as promising tools involved in many pathophysiological processes in various fields, including cardiovascular diseases. In acute coronary syndromes (ACS), circulating levels of miRNAs are significantly elevated, as an indicator of cardiac damage, making them a promising marker for early diagnosis of myocardial infarction. They also have prognostic value and great potential as therapeutic targets considering their key function in gene regulation. This review aims to summarize current information about miRNAs and their role as diagnostic, prognostic and therapeutic targets in STEMI patients.
机译:尽管诊断和治疗进展,冠状动脉疾病,尤其是其极端表现,St 000左右心肌梗死(Stemi)仍然是全世界发病率和死亡率的主要原因。早期和及时​​的诊断对于STEMI患者的预后是非常重要的。近年来,MicroRNA(MIRNA)被出现为有前途的工具,涉及各种领域的许多病理生理过程,包括心血管疾病。在急性冠状动脉综合征(ACS)中,作为心脏损伤的指标,MIRNA的循环水平显着升高,使其成为早期诊断心肌梗死的有希望的标志物。考虑到基因调控中的关键功能,它们还具有预后值和巨大潜力作为治疗目标。该审查旨在总结当前关于MiRNA的当前信息及其作为Stemi患者诊断,预后和治疗靶标的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号